Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials
First Antiviral Drug in Glycovirology: Bioxytran Announces FDA Clearance of its IND Application for ProLectin-M in Clinical Trials Bioxytran, Inc. (BIXT) (NASDAQ:BIXT) BOSTON, MASSACHUSETTS, UNITED STATES, August 30, 2023 /EINPresswire.com/ -- …